A Phase 1 Clinical Trial to Evaluate Safety and Pharmacokinetic Characteristics after Administration of the "SJP003" in Healthy Male Volunteers
Latest Information Update: 24 Sep 2019
At a glance
- Drugs SJP 003 (Primary)
- Indications Blood coagulation disorders
- Focus Pharmacokinetics
- Sponsors Samjin Pharmaceutical Company
Most Recent Events
- 24 Sep 2019 New trial record